LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2012-02-22
- Last Posted Date
- 2016-09-19
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 376
- Registration Number
- NCT01536886
- Locations
- 🇺🇸
Dermatology Research Associates, Los Angeles, California, United States
🇺🇸Altman Dermatology Associates, Arlington Heights, Illinois, United States
🇺🇸Menter Dermatology Research Institute, Dallas, Texas, United States
LEO 90100 in the Treatment of Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2012-02-22
- Last Posted Date
- 2016-05-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 303
- Registration Number
- NCT01536938
- Locations
- 🇺🇸
Dermatology Research Associates, Los Angeles, California, United States
🇺🇸Altman Dermatology Associates, Arlington Heights, Illinois, United States
🇺🇸Derm Research Center of New York, Stony Brook, New York, United States
An Exploratory Psoriasis Plaque Test Study With LEO 29102 Plus Calcipotriol, Ointment, in Psoriasis Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2011-11-08
- Last Posted Date
- 2013-10-25
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT01466478
- Locations
- 🇫🇷
CPCAD - Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Nice, France
Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris
- Conditions
- Interventions
- First Posted Date
- 2011-10-28
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 40
- Registration Number
- NCT01461655
- Locations
- 🇫🇷
CPCAD - Centre de Pharmacologie Clinique Appliquée à la Dermatologie, Nice, France
PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy
- First Posted Date
- 2011-10-10
- Last Posted Date
- 2016-05-09
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 24
- Registration Number
- NCT01449513
- Locations
- 🇩🇪
Charité - Universitätsmedizin Berlin, Berlin, Germany
Safety, Tolerability and Pharmacokinetics of LEO 29102 Cream in Atopic Dermatitis.
- Conditions
- Interventions
- First Posted Date
- 2011-10-06
- Last Posted Date
- 2013-05-01
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 58
- Registration Number
- NCT01447758
- Locations
- 🇩🇪
Universitätshautklinik Essen, Essen, Germany
🇩🇪Clinical Trial Center North, Hamburg, Germany
🇩🇪Department of Dermatology, Johann Wolfgang Goethe-University, Frankfurt/Main, Germany
21 Day Irritancy Test of Azelaic Acid Pre-foam Formulation
- Conditions
- Interventions
- First Posted Date
- 2011-09-08
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 40
- Registration Number
- NCT01430312
- Locations
- 🇺🇸
Robert I. Cooper, MD, Fargo, North Dakota, United States
Human Repeated Insult Patch Test (HRIPT) of Azelaic Acid Pre Foam Formulation
- Conditions
- Interventions
- First Posted Date
- 2011-09-08
- Last Posted Date
- 2020-04-01
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 240
- Registration Number
- NCT01430533
- Locations
- 🇺🇸
Robert I. Cooper, MD, Fargo, North Dakota, United States
Safety, Tolerability and Pharmacokinetic Study in Healthy Subjects by Dermal Application of a LEO 29102
- First Posted Date
- 2011-08-26
- Last Posted Date
- 2013-01-28
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 102
- Registration Number
- NCT01423656
- Locations
- 🇬🇧
Covance Clinical Research Unit Ltd., Leeds, United Kingdom
LEO 90105 Ointment in Japanese Subjects With Psoriasis
- Conditions
- Interventions
- First Posted Date
- 2011-08-24
- Last Posted Date
- 2015-04-14
- Lead Sponsor
- LEO Pharma
- Target Recruit Count
- 676
- Registration Number
- NCT01422434
- Locations
- 🇯🇵
Tokai University School of Medicine, Isehara, Kanagawa, Japan